On this episode of "Halteres Presents", Rich Thayer and Mickey Urdea are chatting about decentralized diagnostic testing with Dr. Donna Wolk, division director of Molecular and Microbial Diagnostics and Development at Geisinger Medical Laboratories. Dr. Wolk helps to put into perspective the market explosion of decentralized diagnostic tests designed for point-of-care, near-patient, at-home, over-the-counter, and pharmacy-based use, and the patient-driven factors to weigh when considering which tests to offer in which decentralized venues.
Dr. Donna Wolk is the division chief, Molecular and Microbial Diagnostics and Development, at Geisinger Medical Laboratories and director of the Infectious Disease Research Laboratory at the Weis Research Center. She is a diplomate of the American Board of Medical Microbiology, a board-certified medical laboratory scientist, and a professor at the Geisinger Commonwealth School of Medicine. Dr. Wolk also serves on the faculty of the Geisinger Pathology Residency Program.
Dr. Wolk received her master’s in health administration at Wilkes University and her Ph.D. at the University of Arizona in Tucson. She completed a postdoctoral fellowship in clinical and molecular microbiology at the Mayo School of Graduate Medical Education in Rochester, Minnesota.
This episode of "Halteres Presents" is brought to you by the UC San Diego Extended Studies In Vitro Diagnostics Product Development course, a unique live-online program designed for managers, entrepreneurs, investors, and scientists. Enroll today and use our exclusive discount code HALTERES10 at checkout for 10% off the price of your enrollment.
Podden och tillhörande omslagsbild på den här sidan tillhör
Halteres Associates. Innehållet i podden är skapat av Halteres Associates och inte av,
eller tillsammans med, Poddtoppen.
